home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

101.74 +0.18 (+0.18%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday? ↗

November 04, 2025

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date...

Via Benzinga

These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

Earnings Preview: Exact Sciences ↗

October 31, 2025

Via Benzinga

Amazon To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 04, 2025

Via Benzinga

EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth

November 04, 2025

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year...

Via StockStory

Exact Sciences to Participate in November Investor Conference

November 04, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences (EXAS) Q3 2025 Earnings Transcript ↗

November 03, 2025

Exact Sciences (EXAS) Q3 2025 Earnings Transcript

Via The Motley Fool

Topics Earnings

Exact Sciences (NASDAQ:EXAS) Reports Upbeat Q3, Stock Soars

November 03, 2025

Via StockStory

Exact Sciences Flirts With A Breakout On Guidance Hike, Sales Beat ↗

November 03, 2025

Exact Sciences stock jumped late Monday on strong third-quarter sales, despite continued losses. The company raised its sales guide.

Via Investor's Business Daily

Topics Earnings

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 03, 2025

Via Benzinga

Exact Sciences Announces Third Quarter 2025 Results

November 03, 2025

From Exact Sciences Corp.

Via Business Wire

Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday? ↗

November 03, 2025

Wall Street opened the week on a mixed note on Monday.

Via Benzinga

Should You Buy Exact Sciences Stock Before Nov. 3? ↗

November 02, 2025

The company's outlook is improving as its innovative ways continue to pay off.

Via The Motley Fool

Exact Sciences (EXAS) Reports Q3: Everything You Need To Know Ahead Of Earnings

November 01, 2025

Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be announcing earnings results this Monday after market hours. Here’s what to expect.

Via StockStory

3 Unprofitable Stocks with Questionable Fundamentals

October 30, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

3 Cash-Producing Stocks We Think Twice About

October 28, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps

October 27, 2025

From Exact Sciences Corp.

Via Business Wire

11 Analysts Have This To Say About Exact Sciences ↗

October 22, 2025

Via Benzinga

Immuno-Oncology Stocks Q2 Recap: Benchmarking Exact Sciences (NASDAQ:EXAS)

October 21, 2025

Looking back on immuno-oncology stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Exact Sciences (NASDAQ:EXAS) and its peers.

Via StockStory

Topics Artificial Intelligence

3 High-Flying Stocks We Steer Clear Of

October 17, 2025

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated...

Via StockStory

Topics Firearms

Exact Sciences Schedules Third Quarter 2025 Earnings Call

October 08, 2025

From Exact Sciences Corp.

Via Business Wire

New Study in Journal of the National Cancer Institute Finds Cologuard Plus™ Provides the Most Life-Years Gained with the Fewest Colonoscopies

October 07, 2025

From Exact Sciences Corp.

Via Business Wire

What Analysts Are Saying About Exact Sciences Stock ↗

October 02, 2025

Via Benzinga

Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures

October 02, 2025

A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human...

Via MarketMinute

Topics Artificial Intelligence Derivatives

Exact Sciences (EXAS) Stock Trades Up, Here Is Why

September 25, 2025

Shares of diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) jumped 2.2% in the afternoon session after the Nancy Gardner Sewell MCED Act advanced in the U.S. House, a development that could...

Via StockStory

Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test

September 22, 2025

From Exact Sciences Corp.

Via Business Wire

Peering Into Exact Sciences's Recent Short Interest ↗

September 18, 2025

Via Benzinga

Demystifying Exact Sciences: Insights From 9 Analyst Reviews ↗

September 11, 2025

Via Benzinga

Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test

September 10, 2025

From Exact Sciences Corp.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com